BioSpace News Archive

Business

Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, announced the promotion of Tom Teisseyre, Ph.D. to chief operating officer.

July 18, 2023
·
6 min read
Business

Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance

Harrow announced the following select preliminary second quarter 2023 financial guidance.

July 18, 2023
·
5 min read
Business

Exelixis to Release Second Quarter 2023 Financial Results on Tuesday, August 1, 2023

Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2023 financial results will be released on Tuesday, August 1, 2023 after the markets close.

July 18, 2023
·
2 min read
Biotech Bay

Protagonist Therapeutics Reports Granting of Inducement Award - July 18, 2023

Protagonist Therapeutics, Inc. reported that on July 17, 2023, it issued inducement awards to Peter Morello, Ph.D. the Company’s recently hired Vice President, Medical Communications and Publication Planning, in accordance with the terms of Dr. Morello’s employment offer letter.

July 18, 2023
·
2 min read
Business

Baxter Declares Quarterly Dividend - July 18, 2023

Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.

July 18, 2023
·
1 min read
Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America

Santen Pharmaceutical Co., Ltd. announced that it has signed licensing agreements and an asset transfer agreement with two U.S. companies.

July 18, 2023
·
2 min read
Business

Secretome Therapeutics Appoints Margot Connor as Board Director and Assembles World-Class Clinical Advisory Board

Secretome Therapeutics, a biotechnology company developing first-in-class therapeutics from neonatal mesenchymal stem cells (nMSC) today announced the appointment of Margot Connor to its Board of Directors.

July 18, 2023
·
2 min read
Drug Development

EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager™ System in Patients with Recurrent Glioblastoma”

EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma in the Journal CNS Oncology https://www.futuremedicine.com/doi/10.2217/cns-2022-0016.

July 18, 2023
·
5 min read
argenx raises $1.1 billion in gross proceeds in a global offering

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the pricing of a global offering of ordinary shares, which may be represented by American Depository Shares.

July 18, 2023
·
9 min read
Business

Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter 2023 on Monday, August 7, 2023.

July 18, 2023
·
1 min read